FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

GenoGenix Thymosin Beta-4 Recall

Thymosin Beta-4 (TB4) for Injection, 15mg, all presentations, GenoGenix, LLC, 2840 NW 2…

GenoGenix LLC · Boca Raton, FL

Risk level
Class II
Reported by FDA
Oct 15, 2025
Recall ID
D-0087-2026
Check your lot numberHow we source this data

Summary

GenoGenix recalled Thymosin Beta-4 starting Jul 30, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0087-2026 on Oct 15, 2025. Reason: Lack of Assurance of Sterility. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility

Product description

Thymosin Beta-4 (TB4) for Injection, 15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

Lot numbers, UPCs & expiration codes

Lot#: GG060525-001 within expiry.

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0087-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jul 30, 2025
FDA report date
Oct 15, 2025
Recall type
Voluntary: Firm initiated
Recalling firm
GenoGenix LLC

Original FDA data

Every field from FDA enforcement report D-0087-2026, exactly as published.

Show all FDA fields
City
Boca Raton
State
FL
Status
Ongoing
Country
United States
Event ID
97369
Address
2840 Nw 2nd Ave Ste 204
Code information
Lot#: GG060525-001 within expiry.
Postal code
33431-6692
Report date
Oct 15, 2025
Product type
Drugs
Recall number
D-0087-2026
Classification
Class II
Recalling firm
GenoGenix LLC
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Thymosin Beta-4 (TB4) for Injection, 15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.
Distribution pattern
US Nationwide.
Recall initiation date
Jul 30, 2025
Initial firm notification
Letter
Center classification date
Oct 21, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0087-2026, published Oct 15, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls